These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22036866)

  • 1. Why do anti-inflammatory therapies fail to improve insulin sensitivity?
    Gao ZG; Ye JP
    Acta Pharmacol Sin; 2012 Feb; 33(2):182-8. PubMed ID: 22036866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and insulin resistance.
    Shoelson SE; Lee J; Goldfine AB
    J Clin Invest; 2006 Jul; 116(7):1793-801. PubMed ID: 16823477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation during obesity is not all bad: evidence from animal and human studies.
    Ye J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E466-77. PubMed ID: 23269411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages, immunity, and metabolic disease.
    McNelis JC; Olefsky JM
    Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance.
    Ye L; Liang S; Guo C; Yu X; Zhao J; Zhang H; Shang W
    Life Sci; 2016 Dec; 166():82-91. PubMed ID: 27702567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.
    Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM
    Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on immune dysregulation in obesity-related insulin resistance.
    Daryabor G; Kabelitz D; Kalantar K
    Scand J Immunol; 2019 Apr; 89(4):e12747. PubMed ID: 30593678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol.
    Bhatt M; Rudrapatna S; Banfield L; Bierbrier R; Wang PW; Wang KW; Thabane L; Samaan MC
    BMC Res Notes; 2017 Aug; 10(1):374. PubMed ID: 28789665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
    Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
    Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
    Ballak DB; Stienstra R; Tack CJ; Dinarello CA; van Diepen JA
    Cytokine; 2015 Oct; 75(2):280-90. PubMed ID: 26194067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.
    Kuryłowicz A; Koźniewski K
    Molecules; 2020 May; 25(9):. PubMed ID: 32397353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.
    Winer DA; Winer S; Chng MH; Shen L; Engleman EG
    Cell Mol Life Sci; 2014 Mar; 71(6):1033-43. PubMed ID: 24127133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle inflammation and insulin resistance in obesity.
    Wu H; Ballantyne CM
    J Clin Invest; 2017 Jan; 127(1):43-54. PubMed ID: 28045398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of immune cells in obesity induced low grade inflammation and insulin resistance.
    Asghar A; Sheikh N
    Cell Immunol; 2017 May; 315():18-26. PubMed ID: 28285710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes.
    Ye J
    Front Med; 2015 Jun; 9(2):139-45. PubMed ID: 25511621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to target inflammation in type 2 diabetes.
    Goldfine AB; Fonseca V; Shoelson SE
    Clin Chem; 2011 Feb; 57(2):162-7. PubMed ID: 21098138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
    Foryst-Ludwig A; Hartge M; Clemenz M; Sprang C; Hess K; Marx N; Unger T; Kintscher U
    Cardiovasc Diabetol; 2010 Oct; 9():64. PubMed ID: 20955583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.